NCT07062627
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Asan Medical Center Seoul, South Korea
Clinical trial condition
Diffuse Large B Cell Lymphoma (DLBCL)
Explore clinical trials studying Diffuse Large B Cell Lymphoma (DLBCL). Study availability and eligibility vary by location and protocol.
37 public trials
16 recruiting studies
Diffuse Large B Cell Lymphoma (DLBCL) trial results
NCT05107674
- Conditions
- Adenoma, Adnexal Diseases, Breast Diseases, +75 more
- Locations
-
- City of Hope Duarte, California, United States
- University of Southern California Los Angeles, California, United States
- University of California, San Francisco San Francisco, California, United States
- University of Colorado School of Medicine Aurora, Colorado, United States
NCT07124936
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Peking University Cancer Hospital Beijing, Beijing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
- The Affiliated Tumor Hospital of Guangxi Medical University Nanning, Guangxi, China
Recruiting
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
NCT06793410
- Conditions
- Acute Myeloid Leukaemia, Bone Marrow Diseases, Communicable Diseases, +32 more
- Locations
-
- Skåne's University Hospital Lund, Region Skåne, Sweden
- Karolinska University Hospital Stockholm, Region Stockholm, Sweden
- Uppsala University Hospital Uppsala, Region Uppsala, Sweden
- Linköping University Hospital Linköping, Region Östergötaland, Sweden
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy
- AO Sant'Anna e San Sebastiano di Caserta Caserta, Italy
- A.R.N.A.S. Garibaldi Catania, Italy
- Azienda Ospedaliera Universitaria Arcispedale S. Anna Ferrara, Italy
NCT06647940
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University, Guangzhou, China
- Gansu Cancer Hospital Lanzhou, Gansu, China
- Dongguan People's Hospital Dongguan, Guangdong, China
- Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
Enrolling by Invitation
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
NCT07168486
- Conditions
- B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
- Locations
-
- University of Maryland, Baltimore Baltimore, Maryland, United States
Not Yet Recruiting
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
NCT07735533
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
- Locations
-
Not specified
Not Yet Recruiting
A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas
NCT07713459
- Conditions
- CAR T Cell Therapy, Diffuse Large B Cell Lymphoma (DLBCL), Follicular B-cell Non-Hodgkin's Lymphoma, +14 more
- Locations
-
Not specified
Not Yet Recruiting
A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07599423
- Conditions
- Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China